We use our expertise to address a variety of therapeutic areas including cardiovascular disorders, central nervous system disorders, infectious diseases, cancer, and immunological disorders. In addition, during 2010, we have integrated two new areas of focus - fibrosis and neurodegeneration. We aim to tackle diseases through multiple mechanisms, delivering novel therapies to patients, with maximum impact on the selected diseases.